HUMAN DATA TRIALS BY REVALIA
Live / Allowed — Publication / registration review complete (as of 16 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99410170
- Mark type
- Stylized text
- Filed
- 24 Sept 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Alesha M. Dominique
Goods and services
- Class 042 — Scientific and technological services: Platform as a service (PAAS) featuring computer software platforms for database management services for human biological and medical data; Scientific and technological services, namely, research and development for performing studies on isolated human organs outside of the body for use in drug discovery and development in the field of human biological and medical research
Owner
- Revalia Bio, Inc., New Haven, CT, US
Prior registrations
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Feb 2026 — NON-FINAL ACTION E-MAILED
- 19 Feb 2026 — NON-FINAL ACTION WRITTEN
- 17 Feb 2026 — ASSIGNED TO EXAMINER
- 09 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Sept 2025 — NEW APPLICATION ENTERED